Aqueous Lignin Solvation Using Good's Buffers for Biocompatibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Lignin's hydrophobicity and insolubility in water limit its utility in biological and medical applications, requiring chemical derivatization or use of toxic solvents for solvation, which is undesirable.

Innovation Solution

Solvation of lignin in biologically compatible Good's buffers (GB) solutions, such as zwitterionic N-substituted aminosulfonic acids like MOPS, EPPS, or CAPS, to create aqueous lignin solutions suitable for various applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If lignin is solvated using conventional methods (strong bases, organic solvents, ionic liquids), then solubility is achieved, but toxicity and incompatibility with biological applications occur

Engineering Contradiction:
Improvelignin solubilityVSAvoidtoxicity and biological incompatibility
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters of the solvation system by replacing conventional solvents (strong bases, organic solvents, ionic liquids) with Good's buffers - zwitterionic compounds that provide a biologically compatible aqueous environment. This parameter change maintains lignin solubility while eliminating toxicity, enabling biological applications

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Good's buffers act as intermediary substances that mediate between lignin's hydrophobic nature and the aqueous biological environment. These zwitterionic compounds interact with lignin to solvate it without requiring toxic conventional solvents, serving as a bridge that enables biological compatibility

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If lignin is chemically derivatized to improve solubility, then solvation in aqueous media is achieved, but additional processing steps and cost are required

Engineering Contradiction:
Improveaqueous solubilityVSAvoidderivatization process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent extracts the solvation function from the lignin molecule itself (which would require chemical modification) and places it in the solvent system (Good's buffers). This allows unmodified lignin to be solvated in aqueous media without chemical derivatization, eliminating the need for additional processing steps

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of modifying lignin to make it soluble (changing the solute), the patent inverts the approach by modifying the solvent system to accommodate unmodified lignin. Good's buffers are used as the solvent to directly solvate native lignin, reversing the conventional derivatization strategy

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The described aqueous lignin solutions are non-toxic, easily preparable, and compatible with biological and medical uses, offering opportunities for value-added products and applications without the need for chemical derivatization or toxic solvents.

Implementation Method 1

for its phenolic hydroxyl and methoxyl groups to undergo intermolecular hydrogen-bonding

Methodology Applied
Scientific EffectHydrogen bonding: Hydrogenation

Implementation Method 2

The propensity of lignin's aromatic rings to participate in 7-7 stacking cause lignin to behave hydrophobically in water, forming largely insoluble aggregates

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS12582670B2Lignin solvation using aqueous biologically compatible buffers
Publication Date: 2026.03.24 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US12582670B2 patent drawing
  • US12582670B2 patent drawing
  • US12582670B2 patent drawing

AI summary

Provided are aqueous lignin solutions containing lignin solvated in Good's Buffers. The aqueous lignin solutions can be used in a variety of applications including biomedical research and in manufacturing a variety of lignin containing products including food grade and biomedical products. The aqueous lignin solutions can also be used in the treatment of microbial infection, as an adjuvant in antimicrobial therapeutics or therapy, and in forming antimicrobial products. Methods of making and using aqueous lignin solutions are also described.